Medicare Enrolled
Dr. Michael Sherman, M.D., PHD
Hematology & Oncology · Walnut Creek, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sherman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sherman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sherman
Dr. Michael Sherman is a hematology & oncology specialist in Walnut Creek, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Sherman performed 213,044 Medicare services across 3,356 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sherman received a total of $61,526 from 128 pharmaceutical and/or device companies across 2480 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sherman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 2% volume in CA
$61,526 industry payments
Medicare Practice Summary
Medicare Utilization ↗213,044
Medicare services
Top 2% in CA for hematology & oncology
3,356
Unique beneficiaries
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~11,836 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
76,200 | $2 | $10 |
| Denosumab injection (Prolia/Xgeva) | 38,820 | $18 | $50 |
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
37,500 | $1 | $3 |
| Pembrolizumab injection (Keytruda) | 15,200 | $43 | $123 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
12,900 | $0 | $5 |
| Injection, docetaxel, 1 mg | 6,573 | $1 | $2 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
5,801 | $0 | $1 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,154 | $0 | $1 |
| Injection, granisetron hydrochloride, 100 mcg | 2,440 | $0 | $2 |
| Romiplostim injection, 10 micrograms An injection of romiplostim containing 10 micrograms of the medication. |
1,768 | $73 | $205 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,750 | $1 | $5 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,377 | $116 | $230 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
1,200 | $79 | $400 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
1,153 | $166 | $310 |
| Piflufolastat F-18 diagnostic injection A diagnostic injection of the radioactive tracer piflufolastat F-18 used for imaging. The dose specified is 1 millicurie. |
935 | $485 | $700 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
830 | $14 | $50 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
575 | $141 | $400 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
523 | $16 | $75 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
521 | $78 | $154 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
463 | $1,625 | $3,475 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 374 | $288 | $600 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
218 | $69 | $250 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
192 | $30 | $75 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
190 | $34 | $100 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
187 | $66 | $182 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
166 | $29 | $150 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
159 | $7 | $20 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
156 | $97 | $200 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
140 | $1 | $3 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
122 | $40 | $125 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
114 | $59 | $150 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
109 | $21 | $100 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
107 | $1 | $5 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
100 | $82 | $482 |
| On-body injector for subcutaneous injection A device is applied to the skin to automatically deliver a medication injection under the skin. |
100 | $19 | $50 |
| New patient office visit, complex (60-74 min) | 91 | $196 | $500 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 88 | $135 | $275 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
87 | $26 | $50 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
85 | $29 | $220 |
| Gallium Ga-68 gozetotide diagnostic injection A diagnostic injection of the radiopharmaceutical Gallium Ga-68 gozetotide (brand name Illuccix) used for imaging purposes. |
75 | $840 | $1,500 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
70 | $34 | $175 |
| Injection, hydrocortisone sodium succinate, up to 100 mg | 54 | $13 | $30 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
50 | $221 | $606 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
43 | $58 | $80 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
41 | $37 | $40 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
40 | $72 | $80 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
37 | $13 | $100 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
37 | $1 | $40 |
| Whole body nuclear medicine scan with CT A combined imaging procedure using nuclear medicine and CT scans to visualize the entire body. |
36 | $1,640 | $4,000 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
32 | $115 | $625 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
31 | $27 | $50 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
18 | $181 | $650 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
12 | $108 | $220 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
18.2% high complexity
79.8% medium
2.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$61,526
Total received (2018-2024)
Avg $8,789/year across 7 years
Top 10% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
128
Companies
2,480
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$46,315 (75.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$13,194 (21.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,017 (3.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$8,865
2023
$8,361
2022
$13,588
2021
$6,944
2020
$9,228
2019
$5,398
2018
$9,142
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$858
Janssen Biotech, Inc.
$835
PFIZER INC.
$614
Merck Sharp & Dohme LLC
$431
GlaxoSmithKline, LLC.
$338
Genentech USA, Inc.
$306
Celgene Corporation
$295
Novartis Pharmaceuticals Corporation
$278
US Oncology Corporate, Inc.
$271
Eisai Inc.
$230
E.R. Squibb & Sons, L.L.C.
$214
Takeda Pharmaceuticals U.S.A., Inc.
$213
Karyopharm Therapeutics Inc.
$210
Lilly USA, LLC
$206
Astellas Pharma US Inc
$184
ABBVIE INC.
$179
Daiichi Sankyo Inc.
$177
SpringWorks Therapeutics, Inc.
$166
Coherus Biosciences Inc.
$145
Galvanize Therapeutics, Inc
$134
ARRAY BIOPHARMA INC
$115
TerSera Therapeutics LLC
$108
Regeneron Healthcare Solutions, Inc.
$103
JAZZ PHARMACEUTICALS INC.
$101
GENZYME CORPORATION
$101
Spectrum Pharmaceuticals Inc.
$100
BeiGene USA, Inc.
$99
PUMA BIOTECHNOLOGY, INC.
$89
SOBI, INC
$87
Octapharma USA, Inc.
$87
EMD Serono, Inc.
$85
Kyowa Kirin, Inc.
$82
Stemline Therapeutics Inc.
$76
Genmab U.S., Inc.
$76
Agios Pharmaceuticals, Inc.
$74
Ipsen Biopharmaceuticals, Inc
$74
Acrotech Biopharma Inc.
$72
Phathom Pharmaceuticals, Inc.
$72
Mirati Therapeutics, Inc.
$71
Alexion Pharmaceuticals, Inc.
$70
Gilead Sciences, Inc.
$66
Exelixis Inc.
$66
Immunocore Limited
$62
PharmaEssentia USA Corporation
$51
Rigel Pharmaceuticals, Inc.
$49
Sumitomo Pharma America, Inc.
$48
SERVIER PHARMACEUTICALS LLC
$44
Aveo Pharmaceuticals, Inc.
$43
Fresenius Kabi USA, LLC
$39
Boehringer Ingelheim Pharmaceuticals, Inc.
$39
Incyte Corporation
$39
RECORDATI_RARE_DISEASES_INC.
$38
Kite Pharma, Inc.
$36
ADC Therapeutics America, Inc.
$33
Azurity Pharmaceuticals, Inc.
$31
Amgen Inc.
$28
Deciphera Pharmaceuticals Inc.
$27
TAIHO ONCOLOGY, INC.
$26
Pharmacosmos Therapeutics Inc.
$21
Fennec Pharmaceuticals, Inc.
$19
SUN PHARMACEUTICAL INDUSTRIES INC.
$17
Blue Earth Diagnostics Limited
$13
Top 3 companies account for 26.0% of 2024 payments
All-time payments by company (2018-2024) ›
Dendreon Pharmaceuticals LLC
$7,017
TESARO, Inc.
$4,271
Janssen Biotech, Inc.
$3,456
GlaxoSmithKline, LLC.
$3,386
AstraZeneca Pharmaceuticals LP
$2,580
PFIZER INC.
$2,356
Exelixis Inc.
$2,346
Genentech USA, Inc.
$2,317
E.R. Squibb & Sons, L.L.C.
$1,799
Amgen Inc.
$1,777
Astellas Pharma US Inc
$1,690
Lilly USA, LLC
$1,344
Celgene Corporation
$1,248
Daiichi Sankyo Inc.
$1,227
Seagen Inc.
$1,163
GENZYME CORPORATION
$1,095
Kite Pharma, Inc.
$970
Octapharma USA, Inc.
$926
Pharmacyclics LLC, An AbbVie Company
$925
TerSera Therapeutics LLC
$880
Takeda Pharmaceuticals U.S.A., Inc.
$839
Novartis Pharmaceuticals Corporation
$801
Eisai Inc.
$725
Merck Sharp & Dohme LLC
$700
Merck Sharp & Dohme Corporation
$684
US Oncology Corporate, Inc.
$610
Gilead Sciences, Inc.
$582
Regeneron Healthcare Solutions, Inc.
$542
Incyte Corporation
$528
PUMA BIOTECHNOLOGY, INC.
$476
Myovant Sciences Inc.
$474
Rigel Pharmaceuticals, Inc.
$388
Karyopharm Therapeutics Inc.
$377
Stemline Therapeutics Inc.
$353
Clovis Oncology, Inc.
$348
Bayer HealthCare Pharmaceuticals Inc.
$348
JAZZ PHARMACEUTICALS INC.
$346
EMD Serono, Inc.
$328
Puma Biotechnology, Inc.
$304
Alexion Pharmaceuticals, Inc.
$292
Foundation Medicine, Inc.
$291
Agios Pharmaceuticals, Inc.
$285
EISAI INC.
$283
Boehringer Ingelheim Pharmaceuticals, Inc.
$274
Galvanize Therapeutics, Inc
$259
BeiGene USA, Inc.
$258
Kyowa Kirin, Inc.
$251
Epizyme, Inc.,
$249
Sumitomo Pharma America, Inc.
$245
ABBVIE INC.
$237
Ipsen Biopharmaceuticals, Inc
$231
Spectrum Pharmaceuticals Inc.
$226
ARRAY BIOPHARMA INC
$221
Coherus Biosciences Inc.
$210
Blueprint Medicines Corporation
$198
McKesson Specialty Care Distribution, LLC
$195
SOBI, INC
$187
SpringWorks Therapeutics, Inc.
$166
SERVIER PHARMACEUTICALS LLC
$162
Mirati Therapeutics, Inc.
$159
Ethicon Inc.
$159
Heron Therapeutics, Inc.
$155
Acrotech Biopharma LLC
$154
Seattle Genetics, Inc.
$151
Genmab U.S., Inc.
$130
Deciphera Pharmaceuticals Inc.
$127
Taiho Oncology, Inc.
$124
Blue Earth Diagnostics Limited
$119
AMAG Pharmaceuticals, Inc.
$112
AbbVie Inc.
$110
PharmaEssentia USA Corporation
$108
AbbVie, Inc.
$100
TAIHO ONCOLOGY, INC.
$96
Acrotech Biopharma Inc.
$95
CTI BioPharma Corp.
$93
Lexicon Pharmaceuticals, Inc.
$91
Apellis Pharmaceuticals, Inc.
$91
Sobi, Inc
$81
Aurobindo Pharma USA, Inc.
$78
Servier Pharmaceuticals LLC
$78
ADC Therapeutics America, Inc.
$73
RECORDATI_RARE_DISEASES_INC.
$72
MorphoSys, US Inc.
$72
Phathom Pharmaceuticals, Inc.
$72
Pharmacyclics LLC, an AbbVie Company
$71
Aveo Pharmaceuticals, Inc.
$66
TOLMAR Pharmaceuticals, Inc.
$64
Advanced Accelerator Applications
$63
Helsinn Therapeutics (U.S.), Inc.
$63
Sun Pharmaceutical Industries Inc.
$62
Immunocore Limited
$62
Teva Pharmaceuticals USA, Inc.
$60
Jazz Pharmaceuticals Inc.
$56
Bayer Healthcare Pharmaceuticals Inc.
$55
Sirtex Medical Inc
$50
AVEO Pharmaceuticals, Inc.
$48
Dova Pharmaceuticals
$48
Secura Bio, Inc.
$47
Pharmacosmos Therapeutics Inc.
$46
Global Blood Therapeutics, Inc.
$43
Fresenius Kabi USA, LLC
$39
Janssen Pharmaceuticals, Inc
$38
Mylan Institutional Inc.
$37
Shire North American Group Inc
$37
Organon LLC
$32
AtriCure, Inc.
$32
G1 Therapeutics, Inc.
$31
Tactile Systems Technology Inc
$31
Azurity Pharmaceuticals, Inc.
$31
INSYS Therapeutics Inc
$29
Adaptive Biotechnologies Corporation
$28
Verastem, Inc.
$26
Novocure Inc.
$26
Otsuka America Pharmaceutical, Inc.
$25
Acceleron Pharma, Inc.
$24
Immunomedics, Inc.
$22
Myriad Genetic Laboratories, Inc.
$21
Clinigen, Inc.
$21
MAYNE PHARMA INC.
$20
Fennec Pharmaceuticals, Inc.
$19
Clinigen Inc
$18
SUN PHARMACEUTICAL INDUSTRIES INC.
$17
SANOFI-AVENTIS U.S. LLC
$16
UCB, Inc.
$13
CHIESI USA, INC.
$13
Amneal Pharmaceuticals LLC
$13
Kerr Corporation
$12
APO-PHARMA USA, INC.
$12
Top 3 companies account for 24.0% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AKYNZEO · ALIMTA · ALIYA SYSTEM · ALUNBRIG · ASPARLAS · ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM · AVASTIN · AYVAKIT · Abraxane · Alecensa · Aliqopa · Aranesp · Avastin · Axumin · BALVERSA · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Beleodaq · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CERDELGA · CINVANTI · COSELA · CYRAMZA · Cabometyx · Cimzia · Columvi · Copiktra · DARZALEX · DEFERIPRONE · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · ELZONRIS · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EVENITY · Empaveli · Enhertu · Entyvio · Epkinly · Erivedge · Erleada · FARESTON · FERAHEME · FERRIPROX · FOLOTYN · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Farydak · Flexitouch Plus · Folotyn · Fulphila · GAVRETO · GAZYVA · GILOTRIF · HEMADY · Halaven · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · IMLYGIC · INFLECTRA · INJECTAFER · INLYTA · INREBIC · Imbruvica · Inrebic · JADENU · JAKAFI · JAYPIRCA · JEMPERLI · JEVTANA · KANJINTI · KAVO MASTERMATIC · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · Lupron · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · N/A · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONCASPAR · ONTRUZANT · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Ocrevus · Oncology · Onivyde · Optune · Orserdu · PADCEV · PANZYGA · PIQRAY · PLUVICTO · POLIVY · POSLUMA · POTELIGEO · PROMACTA · PROVENGE · Padcev · Pedmark · Perjeta · Phesgo · Polivy · Pomalyst · Poteligeo · PreciseTumor · Proleukin · Prolia · QINLOCK · QTERN · QUZYTTIR · Quzyttir · REBLOZYL · RETEVMO · ROLVEDON · ROZLYTREK · RYBREVANT · RYZNEUTA · Reblozyl · Revlimid · Rezlidhia · Rituxan · Rituxan Hycela · Rubraca · SANDOSTATIN · SARCLISA · SHINGRIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · SYLVANT · SYNDROS · Stimufend · Stivarga · Sustol · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEPMETKO · TIBSOVO · TIVDAK · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tarceva · Tavalisse · Tazverik · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VARUBI · VENCLEXTA · VERZENIO · VIVIMUSTA · VONJO · VONVENDI · VOQUEZNA · VOTRIENT · VPRIV · VYXEOS · Venclexta · Vitrakvi · Vonjo · Vyloy · WILATE · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · Zevalin · Zoladex · Zydelig · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (75%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for hematology & oncology in CA.
Geographic Context
Hematology & oncology specialists within 10 mi
103
Per 100K population
8.9
County median income
$125,727
Nearest hospital
JOHN MUIR MEDICAL CENTER - WALNUT CREEK CAMPUS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sherman is a mixed practice specialist, with above-average Medicare volume (top 2% in CA), with low-engagement industry engagement in the top 10% of CA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sherman experienced with darbepoetin injection (aranesp) for anemia?
Based on Medicare claims data, Dr. Sherman performed 76,200 darbepoetin injection (aranesp) for anemia services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sherman receive payments from pharmaceutical companies?
Yes. Dr. Sherman received a total of $61,526 from 128 companies across 2,480 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sherman's costs compare to other hematology & oncology specialists in Walnut Creek?
Dr. Sherman's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sherman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Walnut Creek
Browse hematology & oncology specialists in Walnut Creek ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
By company
TESARO, Inc. Payments to Doctors
See all physicians who received payments from TESARO, Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology